Miromatrix Receives New Patent for Its Novel Perfusion Decellularization and Recellularization Technology
August 25, 2022 07:00 ET
|
Miromatrix Medical Inc.
EDEN PRAIRIE, Minn., Aug. 25, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to...
Miromatrix Announces Participation in Upcoming Gilmartin Emerging Growth Company Showcase
August 23, 2022 07:00 ET
|
Miromatrix Medical Inc.
EDEN PRAIRIE, Minn., Aug. 23, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to...
Miromatrix Reports Second Quarter 2022 Results and Provides Corporate Update
August 15, 2022 16:01 ET
|
Miromatrix Medical Inc.
EDEN PRAIRIE, Minn., Aug. 15, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to...
Miromatrix Appoints Jack Lake, M.D., as Medical Director
August 10, 2022 07:00 ET
|
Miromatrix Medical Inc.
EDEN PRAIRIE, Minn., Aug. 10, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to...
Miromatrix to Report Second Quarter 2022 Financial Results
August 01, 2022 16:01 ET
|
Miromatrix Medical Inc.
EDEN PRAIRIE, Minn., Aug. 01, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to...
Miromatrix Applauds the FDA for Its Continued Commitment to the Field of Organ Transplant
July 05, 2022 07:01 ET
|
Miromatrix Medical Inc.
EDEN PRAIRIE, Minn., July 05, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to...
Miromatrix Announces Participation in the 2022 American Transplant Congress
May 31, 2022 16:30 ET
|
Miromatrix Medical Inc.
EDEN PRAIRIE, Minn., May 31, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to...
Miromatrix Announces Participation in the 19th Annual Craig-Hallum Institutional Investor Conference
May 25, 2022 16:30 ET
|
Miromatrix Medical Inc.
EDEN PRAIRIE, Minn., May 25, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to...
Miromatrix Announces Participation in H.C. Wainwright Global Investment Conference
May 17, 2022 16:39 ET
|
Miromatrix Medical Inc.
EDEN PRAIRIE, Minn., May 17, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to...
Miromatrix Reports First Quarter 2022 Results and Provides Corporate Update
May 16, 2022 16:01 ET
|
Miromatrix Medical Inc.
EDEN PRAIRIE, Minn., May 16, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to...